Background and Purpose-The aim of the present study was to test the hypothesis that perfusion single-photon emission computed tomography (SPECT), carried out in addition to transmission computed tomography (TCT), improves the predictive value of brain imaging within the therapeutically relevant time window after acute cerebral ischemia. Methods-Using TCT and [
N ew therapies for acute cerebral infarction have been tested for several years. Among them, intravenous thrombolysis within 3 hours after symptom onset represents the first therapeutical approach that can effectively treat acute ischemic stroke. 1 Although adequate treatment should be started as early as possible, most patients still arrive at the hospital too late to receive the maximum benefit from this emerging therapy. 2 It is evident, however, that viable brain tissue may persist beyond this time. 3, 4 Therefore, thrombolysis was also tested up to 6 hours after symptom onset. [5] [6] [7] Despite the recently published PROACT II trial that first demonstrated the efficiency of intra-arterial thrombolysis, 7 up until now, thrombolysis has not been approved for intravenous administration Ͼ3 hours after stroke onset.
Because these entire therapeutic approaches involve the preservation of jeopardized but viable brain tissue with functional relevance, a diagnostic tool is required that is able to predict the presence of salvageable brain tissue. 8, 9 Transmission computed tomography (TCT) has been the routine brain-imaging method of choice for cases of acute stroke. 10, 11 TCT allows the exclusion of hemorrhagic stroke with high accuracy. 12 In addition, a number of TCT findings provide evidence for an ischemic course of the stroke event: hyperdense middle cerebral artery (MCA) sign, 13 focal hypoattenuation, 14 and focal brain swelling. 15 TCT performed early after stroke onset is able to evaluate brain tissue viability with high specificity 16 : the presence of "early signs" in TCT provides strong evidence for an evolving infarction and reliably excludes reversible ischemia. However, the sensitivity of TCT, especially at very early time points after the stroke, is controversial, as discussed in the literature, 16, 17 and must be further investigated. There also is evidence from the literature that the predictive value of brain imaging in acute ischemia could be improved by the addition of information regarding blood flow to information regarding early ischemic edema, which is obtained with TCT. 9, 18 In a previous study, we demonstrated that single-photon emission computed tomography (SPECT) of the brain with [ 99m Tc]ethyl cysteinate dimer ([ 99m Tc]ECD) within 6 hours after the onset of stroke symptoms is able to differentiate between reversible cerebral ischemia and evolving cerebral infarction. 19 In the case of evolving infarction within the MCA territory, [
99m Tc]ECD-SPECT, performed at the acute stage, allows a prediction of complete ("malignant") infarction. 20 Even clinical outcome can be reliably predicted with early [
99m Tc]ECD-SPECT. 21 Until now, no studies have compared brain TCT with [ 99m Tc]ECD-SPECT within the therapeutically relevant time window of 6 hours, particularly with respect to the identification of (1) patients with spontaneously good prognosis, who do not need specific treatment, (2) patients with evolving infarctions, who would profit from adequate therapy, and (3) patients with the risk of complete (malignant) MCA territory infarctions, 22 in whom clinical outcome probably could be improved by alternative treatment strategies such as decompressive hemicraniectomy or hypothermia. 23, 24 Thus, in the present study, we prospectively tested the hypothesis that [
99m Tc]ECD-SPECT, performed in combination with TCT, can improve the predictive value of non-contrastenhanced TCT alone early after stroke.
Subjects and Methods

Subjects
In this study of combined TCT and SPECT, 108 consecutive patients (44 women, 64 men; mean age 65Ϯ13 years) were prospectively enrolled. All patients had acute neurological deficits attributed to ischemia within the MCA territory, no stroke history, Scandinavian Stroke Scale (SSS) 25 score of Ͻ40 points on admission, and TCT as well as SPECT imaging within 6 hours after the time point at which the acute neurological deficit was first observed. Exclusion criteria were presence of coma, rapid improvement in symptoms during the TCT and SPECT investigations, signs of intracerebral hemorrhage on acute TCT, and symptoms of vertebrobasilar stroke. The study was approved by the Ethics Committee of the University of Leipzig. Of the 108 patients, 39 represent the first group of patients, who were included at the University of Leipzig in an ongoing double-blind, placebo-controlled trial (ECASS II [Second European-Australian Acute Stroke Study] 26 ) and were treated in a randomized manner with recombinant tissue plasminogen activator (nϭ20) or placebo (nϭ19). The SPECT results for the patients who were included in the ECASS II trial at the University of Leipzig were recently published. 27 
Protocol and Clinical Investigation
Immediately after admission to the hospital, all patients were clinically examined, including blood pressure measurement, evaluation of consciousness, eye inspection with respect to putative gaze palsy or conjugate eye deviation, cardiac examination, and SSS (46 points maximum, without "gait"). Clinical examination was followed by TCT and SPECT imaging. To save time, in 43 patients the radiopharmaceutical agent for SPECT imaging was administered directly before TCT. TCT was repeated 7 days after the stroke to evaluate extent and localization of definitive infarctions. SSS was assessed again 30 and 90 days after stroke. Additional functional and disability outcomes were scored after 90 days using the Barthel Activity of Daily Living Index (0 to 100 points) 28 and the Modified Rankin Disability Scale (0 to 6 points). 29 
Brain Imaging
For TCT, all patients underwent non-contrast-enhanced cranial TCT with a Somatom Plus S scanner (Siemens Inc). Axial slices of the whole brain were obtained parallel to the orbitomeatal line. The slice thickness was 5 mm (lower part of brain up to sellar region) and 10 mm (upper part of brain), respectively. Window width equaled 128 Hounsfield units, with the center level at 36 Hounsfield units.
For SPECT, all patients were injected intravenously with 400 to 600 MBq [ 99m Tc]ECD. 30 SPECT acquisition was begun 15 minutes after the injection. Photons were registered with a brain-dedicated SPECT camera (Ceraspect; DSI) with 3 rotating parallel-hole collimators. 31 The SPECT data were acquired, reconstructed, attenuationcorrected, and reoriented according to a standard protocol that has been described elsewhere. 32 
Image Analysis
Interpretation of the acute TCT and SPECT images was performed visually.
Separate Analysis of Early TCT Images
The TCT images were independently evaluated by 3 experienced interpreters. The extent of putative hypodensity and brain swelling in MCA territory (Ͻ33%, 33% to 66%, or Ͼ66% of MCA territory) was rated, as well as the additional involvement of anterior or posterior cerebral artery territories. On the basis of the TCT findings, the outcome was rated as "transient ischemia," "nontotal MCA infarction," or "total MCA infarction." The experts were aware of the affected side but blinded to the severity of symptoms.
Separate Analysis of Early SPECT Images
In the same manner as for the TCT images, the SPECT images (transverse, coronal, and sagittal slices) were independently evaluated by 3 experienced interpreters. These interpreters were also aware of the side of the symptoms but were blinded to the results of the TCT scoring and symptom severity. Extent of local activity deficits within the MCA territory (Ͻ33%, 33 to 66%, to Ͼ66% subtotal and total MCA territory) was scored, as well as severity (0ϭno, 1ϭmild, 2ϭmoderate, 3ϭsevere decrease in activity). Outcome was predicted as described for TCT images.
Combined Analysis of Early SPECT and TCT Images
The SPECT images were reinterpreted as described together with the corresponding individual TCT images.
Categorization
The follow-up TCT images were analyzed by 1 of the experts, who was blinded to the ratings of the initial TCT and SPECT images, concerning the occurrence of hypodensities. According to these findings, the patients were separated into 3 groups: group A (nϭ24) had no hypodensities, group B (nϭ73) had hypodensities in subtotal MCA territory, and group C (nϭ11) had hypodensities in total MCA territory. This grouping was performed with consideration for possible subsequent pooling of the study population according to the different hypotheses to be tested: prediction of evolving subtotal (groups B plus C versus group A) or total (group C versus groups A plus B) MCA territory infarctions.
Statistical Analysis
Differences between the patient groups in the number of SPECT and TCT findings were tested for significance using the Student's t test for independent samples after verification of normal distribution with the statistical software package SPSS. Normal values were given with 1 SD. Significance levels for differences were set at PϽ0.05, PϽ0.01, and PϽ0.001. Interobserver variability of the visual SPECT and TCT analyses was assessed by calculating the statistics for the ratings of each of the 3 independent experts. Receiver operating characteristic (ROC) parameters for results of SPECT and TCT image analyses, as well as clinical findings, were calculated with the software CLABROC for continuously distributed variables and CORROC2 for categorical rating-scale variables. ROC curves were fitted by application of the software ROCFIT. Accuracy, positive predictive value (PPV), negative predictive value (NPV), and relative risk were calculated after cutoff values were defined with the help of the corresponding ROC data and that of cross-tables, respectively. Proportions were presented with 95% CI values. After these univariate analyses, multivariate analyses were performed to identify independent parameters for the prediction of infarction, total MCA territory infarction, or death after stroke. For that, logistic regression analysis was carried out using stepwise forward selection of variables with Wald's testing. Correlations between clinical, TCT, and SPECT data on admission and clinical follow-up parameters were characterized by calculation of Kendall's rank correlation coefficients and (linear) regression analyses.
Results
Patient Characteristics
Group characteristics concerning individual and clinical data for the patients are listed in Table 1 . No significant differences were found between groups A (no hypodensities on final TCT), B (subtotal MCA territory hypodensities on final TCT), and C (total MCA territory hypodensities on final TCT) with respect to age and sex distribution or regarding systolic and diastolic blood pressure and occurrence of cardiac arrhythmia. SSS score on admission was significantly higher in group A patients than in group B and C patients (meanϮSD 36Ϯ3 versus 29Ϯ8 and 25Ϯ7, respectively), whereas the difference between groups B and C was insignificant. Impairment of consciousness, evaluated on admission, was observed significantly more often in group C than in group B. Gaze palsy/conjugate eye deviation occurred in only 4% of patients in group A in comparison to 25% of patients in group B ( Table 1) .
Analysis of Early TCT and Perfusion SPECT Images
In early TCT, hyperdense MCA sign was observed significantly more often in group B than in group A (10% versus 0%, PϽ0.05), as well as focal hypodensities (64% versus 8%, PϽ0.001) and brain swelling (51% versus 4%, PϽ0.001). In a comparison of the findings between groups B and C, a highly significant group difference was found regarding the SPECT imaging was carried out 1.3 to 6.0 hours (mean 4.0Ϯ1.6 hours) after the onset of stroke symptoms, without significant differences within that period, defined as duration between symptom onset and injection of the radiopharmaceutical agent, among the 3 patient groups (Table 1) . With respect to the early SPECT findings, highly significant differences were found between all patient groups: Activity deficits with an extent of Ͼ33% of the MCA territory were more often observed in group B than in group A (76% versus 21%, PϽ0.001), and those in the total MCA territory were more often observed in group C than in group B (64% versus 1%, PϽ0.001). Highly significant differences between groups A and B were further found concerning the frequency of activity deficits with a degree of Ͼ1 in the visual scoring (17% versus 97%, PϽ0.001). Figures 1 and 2 give examples of early imaging results of 2 patients from group C: although in the case of the patient in Figure 1 , early TCT revealed hypodensities and brain swelling in the total MCA territory, in the case of the patient in Figure 2 , hypodensities were rated only in the left putaminal area. Early SPECT imaging, however, showed activity deficits in complete MCA territories in both patients.
Prediction of Evolving Infarction
Patients with final infarctions (groups B and C) were pooled and compared with the patients without final infarction (group A). Predictive values, calculated relative risk in case of the presence of clinical signs on admission, and TCT and SPECT findings for the prediction of evolving cerebral infarction are listed in Table  2 . The highest PPVs and NPVs were found for a parameter of combined interpretation of early TCT and SPECT images: activity deficits in SPECT with a severity of Ͼ1 in visual scoring, which were not caused by local atrophy (PPV 94%, NPV 90%). An example of false-positive scoring in the separate interpretation of the early SPECT images due to local atrophy is illustrated in Figure 3 . Multivariate logistic regression analysis revealed both SSS scoring on admission and severity of activity deficits in SPECT to be independent predictors of evolving infarction. Combination of information from these 2 independent predictors resulted in an accuracy of 91% for the prediction of evolving infarction ( Table 3 ). The application of the optimal clinical, TCT, and SPECT predictors and the combination of their predictive impact according to the course of events within the clinical setting (clinical examination, TCT, brain perfusion SPECT) resulted in stepwise improvement in accuracy from 70% to 83% and 93%. This improvement in accuracy was attributed to an improvement in NPV (Figure 4 ).
Prediction of Total MCA Territory Infarction
The group of patients with a final total MCA territory infarction (group C) was compared with a pool of patients without a final total MCA territory infarction (groups A and B). The highest impact on the prediction of total MCA territory infarction among all clinical and early TCT and SPECT parameters was calculated for the extent of activity deficits in SPECT. Deficits with an extent of 100% of the MCA territory were found in 7 of 11 group C patients and in only 1 of 97 group A and B patients. Multivariate analysis revealed the extent of SPECT defects to be the only independent predictor of total MCA territory infarction (Tables 3 and  4) . ROC analysis resulted in a significant larger area under the ROC curve (AUC) concerning the extent of the activity deficit scored in the early SPECT images (AUC index 0.91) compared with that concerning SSS scoring on admission (AUC index 0.73) and the extent of hypodensities/brain swelling rated on early TCT images (AUC index 0.77, PϽ0.05) ( Figure 5 ). The combination of optimal clinical and early TCT predictors resulted in an improvement in accuracy from 58% to 92%, with further improvement after the addition of SPECT information (94%). This stepwise improvement was the result of substantially higher PPV by adding the parameters of brain imaging to the clinical score ( Figure 6 ).
Prediction of Clinical Outcome
Death after stroke occurred in 12 patients (11%). Among all clinical, TCT, and SPECT parameters, it was optimally predicted with the information on the extent of activity deficits in SPECT (PPV 88%, NPV 95%, PϽ0.001). Activity deficits on SPECT in the total MCA territory, as well as coinvolvement of the territories of the anterior and posterior cerebral arteries to the MCA territory, were revealed to be independent predictors of death after stroke (PϽ0.001 and Ͻ0.012 after multivariate logistic regression analysis). The combination of these 2 independent predictors resulted in an accuracy of 93% (Table 3) . Correlations between parameters of clinical outcome (SSS after 30 and 90 days, Barthel Index after 90 days, and Modified Rankin Scale after 90 days) and clinical parameters on admission as well as early TCT and SPECT parameters are shown in Table 5 : whereas in the case of SSS scoring after both 30 and 90 days, the highest coefficients were calculated for correlation with SSS scoring on admission (rϭ0.50 and 0.52), with respect to the Barthel Index after 90 days and the Modified Rankin Scale after 90 days, the highest coefficients were found for the correlation with the degree of activity deficits on early SPECT (rϭ0.46 and 0.53).
Discussion
The present study was initiated to test whether brain SPECT with [ 99m Tc]ECD, carried out in combination with TCT, can improve the prospective value of brain imaging within 6 Combinations of all independent parameters (result of multivariate logistic regression analyses) were tested. * 2 testing. SPECT/TCT, activity deficit severity Ͼ1 in SPECT, not caused by local atrophy in TCT; CD, SSS scoring Ͻ33 points; SPECT 1 , activity deficit in total MCA territory; SPECT 2 , coinvolvement of ACA and PCA territory. hours after the onset of stroke symptoms. Both imaging modalities were first applied in a time window in which decisions regarding treatment can be derived from the obtained diagnosis. Previous studies that compared brain perfusion SPECT and TCT in early stages (within 48 hours) of stroke were carried out, with the only exception being a study by Giubilei et al 33 of 32 patients, Ͼ6 hours after stroke symptom onset. 34 -39 Because until now optimal treatment strategy beyond the 6-hour time window has not been found, diagnosis at this time after stroke in most cases lacks therapeutical relevance. Therefore, in the present study, we included only patients (nϭ108) who underwent both TCT and [
99m Tc]ECD-SPECT imaging within 6 hours after the onset of symptoms.
Furthermore, we compared TCT with SPECT images obtained using the radiopharmaceutical agent [
99m Tc]ECD in the acute stage after stroke. The cited studies were exclusively carried out using the local cerebral blood flow (lCBF) 
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By using [ 99m Tc]ECD for high-resolution SPECT and comparing its prognostic impact with that of parameters of clinical status on admission and early TCT, an improvement in the prediction of evolving infarction was achieved. This is particularly evident in borderline situations concerning therapeutical decisions. The combination of admission symptomatology and information obtained with TCT and SPECT allows the prediction of evolving cerebral infarctions with an accuracy of 93% (95% CI 88% to 98%). Symptom severity and severity of perfusion deficits in SPECT were revealed to be the only independent predictors of evolving infarction. However, in cases of an infarction, involvement of the total MCA territory is predicted with a similar accuracy of 94% (95% CI 89% to 98%). Multivariate regression analysis showed potential to independently predict total MCA territory infarction only for SPECT perfusion defects in total MCA territory, not for any early signs of infarction on TCT or clinical data. This advantage of early [
99m Tc]ECD-SPECT was clearly confirmed by additional ROC analysis.
Despite the limited comparability to the above studies, our results of higher predictive values of early SPECT compared with those of early TCT for the prediction of infarction correspond with the results of Giubilei et al, 33 who published the only available study that systematically compared brain perfusion SPECT and TCT within 6 hours after acute stroke. They used [
99m Tc]HMPAO as the lCBF tracer in 32 patients and found that 7 of 8 patients (88%) with large infarctions on follow-up TCT, but without early signs of infarction on acute TCT, had severe perfusion defects in SPECT (asymmetry Ͼ40% compared with contralateral hemisphere). Furthermore, 10 of 11 patients (91%) with smaller final infarctions had accordingly milder perfusion disturbances. 33 These results are paralleled by studies that compare brain perfusion SPECT and TCT for the diagnosis of infarction within time windows of 36 to 48 hours. 34 ). However, a comparison of the predictive values of brain perfusion SPECT and TCT is appropriate, because both procedures are applied within an identical clinical context after acute ischemic stroke.
Our results of a higher predictive value with brain perfusion SPECT compared with TCT are not hampered by a lack of quality in early TCT evaluation: Fiorelli et al 47 evaluated the occurrence of early signs of cerebral infarction in TCT (within 5 hours after symptom onset) in a study of 158 patients and reported a PPV of 97% (95% CI 93% to 100%; present results, 95% to 100%) and an NPV of 40% (95% CI 29% to 51%; present results, 25% to 49%) for focal parenchymal changes. In addition, von Kummer et al 14 reported a PPV of 70% to 85% and an NPV of 83% to 88% of hypodensities and focal brain swelling covering Ͼ50% of the MCA territory for the prediction of fatal clinical outcome (Oxford Handicap Scale Ͼ3). In the present study, focal brain swelling/hypodensities in Ͼ66% of MCA territory predicted total MCA territory infarction with a PPV of 67% (95% CI 29% to 100%) and an NPV of 93% (95% CI 88% to 98%). However, the PPV and NPV of our early TCT evaluation are in accordance with those of Fiorelli et al 47 and von Kummer et al. 14 Tc]ECD-SPECT for the prediction of evolving cerebral infarctions. Optimal PPV and NPV were calculated for perfusion defects that were not caused by local atrophy, whereby this information was obtained from the combined TCT and SPECT image interpretation. In the future, such combined measurements of different pathophysiological parameters could play an important role, particularly in the determination of ischemic penumbra, 48 which represents the target of most stroke therapies 49 and could be diagnosed by combining evaluations of brain tissue viability and blood flow/oxygen concentration. 18, 9, 50 Weir et al 51 investigated a subgroup of 28 stroke patients within 16 hours of symptom onset by using [
99m Tc]HMPAO-SPECT and concluded that the accuracy of clinical follow-up prediction decreases the longer the SPECT imaging is delayed, so we focused on the prediction of clinical outcome of the stroke patients within the early time window of 6 hours. In the comparison of early brain perfusion SPECT with TCT and clinical data on admission, only 2 SPECT parameters regarding the extent of lCBF defects, and no early TCT parameters or clinical data on admission, were found to be independent predictors of death after the stroke (overall accuracy 93%, 95% CI 88% to 98%). Among all clinical and early TCT and SPECT parameters, the functional and disability outcome after 3 months was best correlated with the degree of the initial perfusion defect (rϭ0.06 and 0.53, PϽ0.001). Our results are paralleled by studies of Lees et al 52 and Laloux et al, 37 who reported the volume of SPECT, but not of TCT defects or Canadian Neurological Score on admission, to be a significant predictor of clinical outcome. In contrast to our study, these authors exclusively compared SPECT and TCT results, which were acquired later than the therapeutical relevant time window of 6 hours. 52, 37 In present study study, the interobserver variability of [ 99m Tc]ECD-SPECT interpretation was revealed to be substantially lower than that of TCT interpretation. Only moderate interobserver agreement for TCT analyses was confirmed by von Kummer et al. 53 This problem with the quality of TCT analysis resulted, for example, in the inclusion of 52 patients in the ECASS I trial (8.4% of the ECASS I population) despite extended hypoattenuation in early TCT, which was detected by additional retrospective evaluation. 54 It can be speculated that in the future, not only diagnosis of acute cerebral ischemia but also quality of studies for the testing of new therapeutical strategies of acute stroke can be improved by including such additional diagnostic information, which can be obtained with lower interobserver variability.
A possible limitation of the present study must be considered. Discrimination of the patient groups was performed depending on the results of a follow-up TCT examination after 7 days. Because Baron and Marchal 55 noted that TCT within this period after stroke onset is not optimum for assessment of the extent of the final infarction due to vasogenic edema and mass effects, it cannot be guaranteed that all patients were correctly grouped. In addition, it cannot be completely excluded that the "fogging" effect, in which initially hypodense ischemic areas become isodense compared with normal brain tissue, 56 could have compromised the quality of the follow-up TCT evaluation. However, literature shows that many stroke investigators schedule the follow-up TCT to evaluate the final infarction within the time range of Ϸ5 to 7 days, 36, 39, 57 even in large multicenter trials. 6, 26 In conclusion, the hypothesis that the prospective value of brain imaging within 6 hours after the onset of cerebral ischemia is improved by the application of [ 99m Tc]ECD brain perfusion SPECT in addition to TCT can be confirmed by our results. In the case of irreversible cerebral ischemia, total MCA infarction is predicted with high reliability. Furthermore, the prediction of clinical outcome after acute stroke is improved. Thus, early brain perfusion SPECT in combination with TCT has the potential to become a valuable diagnostic tool in the acute phase after stroke. 
